
### [NCIT:C3513](http://purl.obolibrary.org/obo/NCIT_C3513)
**Label:** Esophageal Carcinoma

**Subclasses:** [NCIT:C133442](http://purl.obolibrary.org/obo/NCIT_C133442) (Esophageal Squamous Cell Carcinoma by AJCC v7 Stage), [NCIT:C133443](http://purl.obolibrary.org/obo/NCIT_C133443) (Esophageal Squamous Cell Carcinoma by AJCC v8 Stage), [NCIT:C133400](http://purl.obolibrary.org/obo/NCIT_C133400) (Esophageal Adenocarcinoma by AJCC v8 Stage), [NCIT:C5022](http://purl.obolibrary.org/obo/NCIT_C5022) (Stage I Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C8632](http://purl.obolibrary.org/obo/NCIT_C8632) (Stage IV Esophageal Adenocarcinoma AJCC v7), [NCIT:C95620](http://purl.obolibrary.org/obo/NCIT_C95620) (Esophageal Large Cell Neuroendocrine Carcinoma), [NCIT:C5023](http://purl.obolibrary.org/obo/NCIT_C5023) (Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C5342](http://purl.obolibrary.org/obo/NCIT_C5342) (Esophageal Adenoid Cystic Carcinoma), [NCIT:C8633](http://purl.obolibrary.org/obo/NCIT_C8633) (Recurrent Esophageal Squamous Cell Carcinoma), [NCIT:C7027](http://purl.obolibrary.org/obo/NCIT_C7027) (Barrett Adenocarcinoma), [NCIT:C8630](http://purl.obolibrary.org/obo/NCIT_C8630) (Stage I Esophageal Adenocarcinoma AJCC v7), [NCIT:C5343](http://purl.obolibrary.org/obo/NCIT_C5343) (Esophageal Mucoepidermoid Carcinoma), [NCIT:C8631](http://purl.obolibrary.org/obo/NCIT_C8631) (Stage III Esophageal Adenocarcinoma AJCC v7), [NCIT:C5020](http://purl.obolibrary.org/obo/NCIT_C5020) (Stage III Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C5021](http://purl.obolibrary.org/obo/NCIT_C5021) (Stage II Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C89795](http://purl.obolibrary.org/obo/NCIT_C89795) (Stage III Esophageal Cancer AJCC v7), [NCIT:C89794](http://purl.obolibrary.org/obo/NCIT_C89794) (Stage II Esophageal Cancer AJCC v7), [NCIT:C91221](http://purl.obolibrary.org/obo/NCIT_C91221) (Esophageal Cancer by AJCC v7 Stage), [NCIT:C95621](http://purl.obolibrary.org/obo/NCIT_C95621) (Esophageal Mixed Adenoneuroendocrine Carcinoma), [NCIT:C89771](http://purl.obolibrary.org/obo/NCIT_C89771) (Stage 0 Esophageal Cancer AJCC v7), [NCIT:C89793](http://purl.obolibrary.org/obo/NCIT_C89793) (Stage I Esophageal Cancer AJCC v7), [NCIT:C95608](http://purl.obolibrary.org/obo/NCIT_C95608) (Esophageal Spindle Cell Carcinoma), [NCIT:C5019](http://purl.obolibrary.org/obo/NCIT_C5019) (Stage IV Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C27421](http://purl.obolibrary.org/obo/NCIT_C27421) (Esophageal Adenosquamous Carcinoma), [NCIT:C8629](http://purl.obolibrary.org/obo/NCIT_C8629) (Stage 0 Esophageal Adenocarcinoma AJCC v7), [NCIT:C133399](http://purl.obolibrary.org/obo/NCIT_C133399) (Esophageal Cancer by AJCC v8 Stage), [NCIT:C8627](http://purl.obolibrary.org/obo/NCIT_C8627) (Recurrent Esophageal Adenocarcinoma), [NCIT:C3999](http://purl.obolibrary.org/obo/NCIT_C3999) (Recurrent Esophageal Carcinoma), [NCIT:C8628](http://purl.obolibrary.org/obo/NCIT_C8628) (Stage II Esophageal Adenocarcinoma AJCC v7), [NCIT:C27422](http://purl.obolibrary.org/obo/NCIT_C27422) (Esophageal Undifferentiated Carcinoma), [NCIT:C4025](http://purl.obolibrary.org/obo/NCIT_C4025) (Esophageal Adenocarcinoma), [NCIT:C133411](http://purl.obolibrary.org/obo/NCIT_C133411) (Esophageal Adenocarcinoma by AJCC v7 Stage), [NCIT:C89804](http://purl.obolibrary.org/obo/NCIT_C89804) (Stage IV Esophageal Cancer AJCC v7), [NCIT:C9213](http://purl.obolibrary.org/obo/NCIT_C9213) (Stage IV Esophageal Cancer AJCC v6), [NCIT:C4024](http://purl.obolibrary.org/obo/NCIT_C4024) (Esophageal Squamous Cell Carcinoma), [NCIT:C6762](http://purl.obolibrary.org/obo/NCIT_C6762) (Esophageal Small Cell Neuroendocrine Carcinoma), [NCIT:C9211](http://purl.obolibrary.org/obo/NCIT_C9211) (Stage II Esophageal Cancer AJCC v6), [NCIT:C9212](http://purl.obolibrary.org/obo/NCIT_C9212) (Stage III Esophageal Cancer AJCC v6), [NCIT:C9210](http://purl.obolibrary.org/obo/NCIT_C9210) (Stage I Esophageal Cancer AJCC v6), [NCIT:C90500](http://purl.obolibrary.org/obo/NCIT_C90500) (Esophageal Cancer by AJCC v6 Stage), [NCIT:C95612](http://purl.obolibrary.org/obo/NCIT_C95612) (Esophageal Poorly Differentiated Squamous Cell Carcinoma), [NCIT:C95611](http://purl.obolibrary.org/obo/NCIT_C95611) (Esophageal Moderately Differentiated Squamous Cell Carcinoma), [NCIT:C27928](http://purl.obolibrary.org/obo/NCIT_C27928) (Alcohol-Related Esophageal Squamous Cell Carcinoma), [NCIT:C95610](http://purl.obolibrary.org/obo/NCIT_C95610) (Esophageal Well Differentiated Squamous Cell Carcinoma), [NCIT:C118812](http://purl.obolibrary.org/obo/NCIT_C118812) (Childhood Esophageal Carcinoma), [NCIT:C3637](http://purl.obolibrary.org/obo/NCIT_C3637) (Stage 0 Esophageal Cancer AJCC v6), [NCIT:C95619](http://purl.obolibrary.org/obo/NCIT_C95619) (Esophageal Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 55.18%
- [NCIT:C118376](http://purl.obolibrary.org/obo/NCIT_C118376) (FGF Gene Amplification) 53.85%
- [NCIT:C118376](http://purl.obolibrary.org/obo/NCIT_C118376) (FGF Gene Amplification) and [NCIT:C36344](http://purl.obolibrary.org/obo/NCIT_C36344) (Oncogene Deregulation) 53.85%
- [NCIT:C41380](http://purl.obolibrary.org/obo/NCIT_C41380) (FGF6 Gene Amplification) 51.92%
- [NCIT:C41379](http://purl.obolibrary.org/obo/NCIT_C41379) (FGF4 Gene Amplification) 51.92%
- [NCIT:C39629](http://purl.obolibrary.org/obo/NCIT_C39629) (CDKN2A Gene Inactivation) 51.92%
- [NCIT:C37189](http://purl.obolibrary.org/obo/NCIT_C37189) (del(17q25)) 51.92%
- [NCIT:C36704](http://purl.obolibrary.org/obo/NCIT_C36704) (FHIT Gene Inactivation) 51.92%
- [NCIT:C36683](http://purl.obolibrary.org/obo/NCIT_C36683) (APC Gene Inactivation) 51.92%
- [NCIT:C36667](http://purl.obolibrary.org/obo/NCIT_C36667) (Loss of Chromosome 4q) 51.92%
- [NCIT:C36652](http://purl.obolibrary.org/obo/NCIT_C36652) (CCND1 Gene Amplification) 51.92%
- [NCIT:C36649](http://purl.obolibrary.org/obo/NCIT_C36649) (EGFR Gene Amplification) 51.92%
- [NCIT:C36644](http://purl.obolibrary.org/obo/NCIT_C36644) (Loss of E-cadherin Expression) 51.92%
- [NCIT:C36641](http://purl.obolibrary.org/obo/NCIT_C36641) (MYC Gene Amplification) 51.92%
- [NCIT:C36638](http://purl.obolibrary.org/obo/NCIT_C36638) (ERBB2 Gene Amplification) 51.92%


